[Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
In the present pilot study we investigated the effects of urso treatment alone in comparison to a combined treatment with urso plus colchicine in PBC. 22 patients with PBC in the histological stages 1-3 entered the study. All patients were pretreated with urso alone (10-12 mg/kg) for 12 months. Thereafter treatment was continued in a double-blind randomized fashion with urso plus placebo or urso plus colchicine (1 mg/day) for another 12 months. During the initial 12 months urso treatment liver function tests improved significantly in all patients, pruritus improved in 60% of patients. After randomization to the different treatment groups the biochemical parameters stabilized at the lower level and no significant differences could be found between urso plus placebo and urso plus colchicine treatment concerning aminotransferases, alkaline phosphatase, bilirubin, cholinesterase, albumin or cholesterol. The results of this pilot study suggest that the addition of colchicine to an initial urso treatment does not lead to further improvement of aminotransferases, alkaline phosphatase, bilirubin or clinical symptoms like pruritus.
Raedsch
R
R
Medizinische Universitätsklinik, Heidelberg/Bundesrepublik Deutschland.
Stiehl
A
A
Walker
S
S
Scherrmann
J M
JM
Kommerell
B
B
D003078:Colchicine / Q000097:blood / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006801:Humans; D008099:Liver / Q000473:pathology; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy* / Q000473:pathology; D008111:Liver Function Tests; D010865:Pilot Projects; D014580:Ursodeoxycholic Acid / Q000097:blood / Q000627:therapeutic use*
D014580:Ursodeoxycholic Acid; D003078:Colchicine
Kombinierte Ursodeoxycholsäure plus Colchizin--Behandlung bei primär biliärer Zirrhose: Ergebnisse einer Placebo-kontrollierten Doppelblindstudie.